Publication | Open Access

A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects

Molecular PharmacologyHypertensionSignal TransductionMolecular PhysiologyFunctional SelectivityMedicinePhysiologyCardiovascular Pharmacology-Independent Beneficial EffectsReceptor (Biochemistry)Vascular BiologyPharmacotherapyPharmacologySmall Difference